These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17209565)

  • 1. Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules.
    Baron RA; Peterson YK; Otto JC; Rudolph J; Casey PJ
    Biochemistry; 2007 Jan; 46(2):554-60. PubMed ID: 17209565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
    Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
    Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
    J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt).
    Baron RA; Casey PJ
    BMC Biochem; 2004 Dec; 5():19. PubMed ID: 15625008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt).
    Ramanujulu PM; Yang T; Yap SQ; Wong FC; Casey PJ; Wang M; Go ML
    Eur J Med Chem; 2013 May; 63():378-86. PubMed ID: 23514631
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mouhcine M; Kadil Y; Segmani I; Rahmoune I; Filali H
    Curr Comput Aided Drug Des; 2024; 20(7):1055-1069. PubMed ID: 38835128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase.
    Go ML; Leow JL; Gorla SK; Schüller AP; Wang M; Casey PJ
    J Med Chem; 2010 Oct; 53(19):6838-50. PubMed ID: 20809634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
    Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
    Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
    Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
    Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
    Svensson AW; Casey PJ; Young SG; Bergo MO
    Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
    Cushman I; Casey PJ
    J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the integral membrane methyltransferase isoprenylcysteine carboxyl methyltransferase (ICMT) reveals potential substrate binding sites.
    Diver MM; Long SB
    J Biol Chem; 2014 Sep; 289(38):26007-26020. PubMed ID: 25059662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT.
    Diver MM; Pedi L; Koide A; Koide S; Long SB
    Nature; 2018 Jan; 553(7689):526-529. PubMed ID: 29342140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth.
    Wang M; Hossain MS; Tan W; Coolman B; Zhou J; Liu S; Casey PJ
    Oncogene; 2010 Sep; 29(35):4959-70. PubMed ID: 20622895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ICMT induces endothelial cell apoptosis through GRP94.
    Lu Q; Harrington EO; Newton J; Jankowich M; Rounds S
    Am J Respir Cell Mol Biol; 2007 Jul; 37(1):20-30. PubMed ID: 17347446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT.
    Yang J; Kulkarni K; Manolaridis I; Zhang Z; Dodd RB; Mas-Droux C; Barford D
    Mol Cell; 2011 Dec; 44(6):997-1004. PubMed ID: 22195972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spermatinamine, the first natural product inhibitor of isoprenylcysteine carboxyl methyltransferase, a new cancer target.
    Buchanan MS; Carroll AR; Fechner GA; Boyle A; Simpson MM; Addepalli R; Avery VM; Hooper JN; Su N; Chen H; Quinn RJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6860-3. PubMed ID: 17964784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.
    Majmudar JD; Hodges-Loaiza HB; Hahne K; Donelson JL; Song J; Shrestha L; Harrison ML; Hrycyna CA; Gibbs RA
    Bioorg Med Chem; 2012 Jan; 20(1):283-95. PubMed ID: 22142613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenylcysteine carboxyl methyltransferase inhibitors exerts anti-inflammatory activity.
    Yang WS; Kim HG; Lee Y; Yoon K; Kim S; Kim JH; Cho JY
    Biochem Pharmacol; 2020 Dec; 182():114219. PubMed ID: 32931773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors.
    Anderson JL; Henriksen BS; Gibbs RA; Hrycyna CA
    J Biol Chem; 2005 Aug; 280(33):29454-61. PubMed ID: 15946942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.